MiMedx Group, Inc.
MDXG
$4.36
-$0.05-1.13%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 14.52% | -53.85% | -63.81% | -44.56% | -27.15% |
| Total Depreciation and Amortization | 146.33% | 280.15% | 196.89% | 159.91% | 76.28% |
| Total Amortization of Deferred Charges | -- | 100.00% | -- | 226.92% | -- |
| Total Other Non-Cash Items | 44.67% | 286.13% | 235.10% | 287.09% | 240.74% |
| Change in Net Operating Assets | -322.89% | -26.36% | 47.79% | 82.17% | 70.49% |
| Cash from Operations | 11.79% | 17.61% | 14.33% | 78.04% | 147.24% |
| Capital Expenditure | 38.62% | 45.26% | 57.03% | 63.33% | 15.30% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 52.12% | -16.66% | 40.44% | 42.76% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5,397.37% | -2,336.90% | 161.44% | -4,575.00% | 77.38% |
| Cash from Investing | 28.14% | -27.70% | 51.02% | 47.15% | -344.69% |
| Total Debt Issued | -- | -100.00% | -100.00% | -100.00% | -- |
| Total Debt Repaid | 98.77% | 98.79% | 98.79% | 98.78% | -- |
| Issuance of Common Stock | -- | -- | -80.47% | -64.15% | 40.22% |
| Repurchase of Common Stock | -18.02% | -18.65% | -24.95% | -36.99% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.52% | 0.35% | 45.79% | 88.12% | -2,280.77% |
| Cash from Financing | 84.17% | 87.77% | 89.75% | 91.41% | -299.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 175.27% | 597.68% | 12,843.38% | 555.03% | 39.66% |